𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Surgical options for localized and advanced gastrointestinal stromal tumors

✍ Scribed by Timothy L. Frankel; Alfred E. Chang; Sandra L. Wong


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
236 KB
Volume
104
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The development of imitinab has led to a revolution in the management of gastrointestinal stromal tumors (GIST), but surgical resection remains the cornerstone of treatment for patients with localized disease. The principles to surgical treatment of GIST include careful handling of tissues to prevent tumor rupture and resection to negative margins without the need for wide excision. Minimally invasive techniques have proven equally efficacious provided appropriate oncologic resections are performed. J. Surg. Oncol. 2011; 104:882–887. Β© 2011 Wiley Periodicals, Inc.


πŸ“œ SIMILAR VOLUMES


Systemic therapy for advanced gastrointe
✍ Edward J. Kim; Mark M. Zalupski πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract Progression on first‐line therapy with imatinib in gastrointestinal stromal tumors (GIST) is caused by either initial resistance or more often a secondary mutation in tyrosine kinases KIT or PDGFR. Therapies in development for imatinib‐resistant GIST include agents that target KIT/PDGFR

Gastrointestinal stromal tumors: From a
✍ Carlo Riccardo Rossi; Simone Mocellin; Roberto Mencarelli; Mirto Foletto; Pierlu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 128 KB

## Abstract Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. These tumors span a wide clinical spectrum from benign to malignant and have long been recognized for their nearly absolute resistance to chemotherapy and radiation treatment. We revie